Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Operating activities:
Net loss	$ (5,178)	$ (31,007)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	1,350	1,914
Goodwill impairment charge	0	23,989
Non-cash lease expense	52	(151)
Change in fair value of warrant liabilities	(123)	(185)
Provision for credit losses	103	0
Stock based compensation	1,088	1,136
Gain on license of patents, net	0	(198)
Changes in operating accounts:
Accounts receivable	2,381	3,611
Prepaid expenses and other assets	33	44
Accounts payable, accrued, and other liabilities	(308)	(498)
Net cash used in operating activities	(602)	(1,345)
Investing activities:
Capital expenditures, net	(4)	(4)
Proceeds from license of patents, net	0	198
Net cash (used in) provided by investing activities	(4)	194
Financing activities:
Proceeds from financing arrangements	384	468
Repayments of financing arrangements	(300)	(289)
Other financing activities	2	2
Net cash provided by financing activities	86	181
Net decrease in cash and cash equivalents	(520)	(970)
Cash and cash equivalents, beginning of period	2,808	7,125
Cash and cash equivalents, end of period	$ 2,288	$ 6,155